This chemical is primarily used in the synthesis of various pharmaceutical compounds, particularly in the development of active pharmaceutical ingredients (APIs). It serves as a key intermediate in the production of drugs that target neurological and psychiatric disorders, such as antidepressants and antipsychotics. Its structure allows for the introduction of trifluoromethoxy groups into molecules, which can enhance the biological activity and metabolic stability of the resulting compounds. Additionally, it is utilized in organic chemistry research for the preparation of hydrazine derivatives, which are valuable in the study of chemical reactions and the development of new therapeutic agents. Its application is crucial in medicinal chemistry for designing molecules with improved efficacy and safety profiles.